MilliporeSigma Webinars
-
Navigating The Regulatory Landscape Of mRNA-Based Therapeutics
7/21/2025
Explore the evolving regulatory landscape of mRNA therapeutics in the EU and US, as well as learn key distinctions and strategic opportunities to optimize your mRNA drug development pipeline.
-
Practical Applications For Controlled And Safe Nucleic Acid Delivery
7/21/2025
Explore the science behind LNP formulation development, from ionizable lipids to scalable manufacturing through case studies, screening strategies, and flexible approaches for advancing next-generation therapeutics.
-
Integrating CPV And APQR Data And Workflows To Reduce Redundant Activities
11/15/2024
Experts in the pharmaceutical industry share insights on how to effectively implement a strong, integrated CPV and APQR framework. Watch now and learn how automation enhances efficiency.
-
Key Quality Attributes For mRNA Drug Substance Performance
5/23/2024
Explore the evolution of the mRNA-based therapeutics pipeline, and gain insights into the key quality attributes and associated analytics that influence mRNA performance, including best practices.
-
How To Bring Your LNP Formulation To Clinical/Commercial Manufacturing
5/23/2024
Gain valuable insights into key considerations when selecting lipid excipients for LNP formulations and the process development steps necessary to advance them to GMP manufacturing and clinical trials.
-
An Early Formulation Screening Service
5/23/2024
Gain insights into overcoming the challenges in lipid nanoparticle (LNP) formulation, explore critical aspects of the process and analytical development of LNPs, and much more.
-
Key Benefits Of PCR-Based mRNA Manufacturing For Clinical Development
6/12/2023
To unlock the potential of your mRNA therapies and accelerate your development and manufacturing program, discover the benefits of a novel PCR-based mRNA drug substance manufacturing process.
-
Establishing Analytical Methods For Emerging mRNA-Based Therapies
6/5/2023
Here, we describe the use of cutting-edge technologies to assess critical quality attributes of both mRNA drug substances and drug products.
-
Plasmid DNA Downstream Purification Process
4/11/2023
Large scale production of plasmid DNA requires an in-depth understanding and optimization of the entire downstream process. Explore a complete solution, from harvest to bulk filtration.
-
RNA Interference - From Single Gene Studies To Whole Genome Screens
11/7/2022
Endoribonuclease-prepared siRNAs (esiRNAs) are able to overcome the limitations of RNAi. Learn about esiRNAs, their advantages over standard siRNAs, and ways this technology is utilized in different research fields.